| Literature DB >> 35410545 |
Li Su1, Shaun R Seaman1, Sean Yiu1.
Abstract
Inverse probability of censoring weighting is a popular approach to handling dropout in longitudinal studies. However, inverse probability-of-censoring weighted estimators (IPCWEs) can be inefficient and unstable if the weights are estimated by maximum likelihood. To alleviate these problems, calibrated IPCWEs have been proposed, which use calibrated weights that directly optimize covariate balance in finite samples rather than the weights from maximum likelihood. However, the existing calibrated IPCWEs are all based on the unverifiable assumption of sequential ignorability and sensitivity analysis strategies under non-ignorable dropout are lacking. In this paper, we fill this gap by developing an approach to sensitivity analysis for calibrated IPCWEs under non-ignorable dropout. A simple technique is proposed to speed up the computation of bootstrap and jackknife confidence intervals and thus facilitate sensitivity analyses. We evaluate the finite-sample performance of the proposed methods using simulations and apply our methods to data from an international inception cohort study of systemic lupus erythematosus. An R Markdown tutorial to demonstrate the implementation of the proposed methods is provided.Entities:
Keywords: Covariate balancing; informative dropout; inverse probability weighting; longitudinal data; missing not at random
Mesh:
Year: 2022 PMID: 35410545 PMCID: PMC9253927 DOI: 10.1177/09622802221090763
Source DB: PubMed Journal: Stat Methods Med Res ISSN: 0962-2802 Impact factor: 2.494
Data generating mechanism for the simulations.
|
| |
|
| |
|
| |
|
| |
Bias, empirical standard deviation (SD) and root mean squared error (MSE) for IPCWEs of in the first simulation study when dropout is sequentially non-ignorable. MLE weights: unscaled MLE weights; SMLE weights: scaled MLE weights; CMLE weights: calibrated weights. The naïve analysis without weighting and the analysis based on complete data are also presented.
|
|
|
|
| ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bias | SD | MSE | Bias | SD | MSE | Bias | SD | MSE | Bias | SD | MSE | ||
|
| |||||||||||||
|
| |||||||||||||
| MLE |
| 3.80 | 3.83 | 2.58 | 2.59 | 1.88 | 1.91 | 1.53 | 1.54 | ||||
|
| 0.76 | 0.97 | 1.24 | 0.60 | 0.86 | 1.05 | 0.59 | 0.62 | 0.85 | 0.52 | 0.65 | 0.83 | |
| SMLE |
| 3.76 | 3.79 | 2.56 | 2.57 | 1.86 | 1.89 | 1.50 | 1.51 | ||||
|
| 0.77 | 0.96 | 1.23 | 0.60 | 0.85 | 1.04 | 0.59 | 0.61 | 0.85 | 0.52 | 0.65 | 0.83 | |
| CMLE |
| 0.30 | 2.74 | 2.76 | 0.23 | 1.75 | 1.77 | 0.18 | 1.23 | 1.24 | 0.20 | 0.90 | 0.92 |
|
| 0.36 | 0.31 | 0.47 | 0.34 | 0.22 | 0.41 | 0.33 | 0.16 | 0.37 | 0.33 | 0.13 | 0.35 | |
|
| |||||||||||||
| MLE |
| 4.81 | 4.92 | 5.18 | 5.23 | 4.97 | 4.99 | 5.15 | 5.18 | ||||
|
| 0.47 | 1.55 | 1.62 | 0.11 | 1.80 | 1.80 | -0.09 | 2.03 | 2.03 | 2.38 | 2.38 | ||
| SMLE |
| 4.63 | 4.75 | 4.52 | 4.58 | 4.26 | 4.29 | 4.34 | 4.37 | ||||
|
| 0.47 | 1.55 | 1.62 | 0.11 | 1.74 | 1.74 | -0.08 | 1.95 | 1.95 | 2.30 | 2.31 | ||
| CMLE |
| 0.18 | 2.80 | 2.81 | 0.12 | 1.84 | 1.84 | 0.11 | 1.37 | 1.38 | 0.13 | 1.25 | 1.26 |
|
| 0.37 | 0.49 | 0.61 | 0.23 | 0.37 | 0.44 | 0.11 | 0.40 | 0.41 | 0.04 | 0.60 | 0.60 | |
|
| |||||||||||||
|
| |||||||||||||
| MLE |
| 3.76 | 3.82 | 2.83 | 2.87 | 2.09 | 2.15 | 1.88 | 1.90 | ||||
|
| 0.54 | 1.04 | 1.17 | 0.31 | 1.04 | 1.09 | 0.28 | 0.76 | 0.81 | 0.16 | 0.84 | 0.86 | |
| SMLE |
| 3.75 | 3.82 | 2.78 | 2.82 | 2.06 | 2.12 | 1.83 | 1.86 | ||||
|
| 0.54 | 1.04 | 1.17 | 0.32 | 1.03 | 1.07 | 0.28 | 0.75 | 0.80 | 0.16 | 0.84 | 0.85 | |
| CMLE |
| 2.77 | 2.77 | 1.78 | 1.78 | 1.25 | 1.25 | 0.92 | 0.93 | ||||
|
| 0.16 | 0.34 | 0.38 | 0.11 | 0.24 | 0.27 | 0.08 | 0.19 | 0.21 | 0.06 | 0.16 | 0.17 | |
|
| |||||||||||||
| MLE |
| 4.28 | 4.39 | 3.84 | 3.91 | 3.83 | 3.88 | 4.41 | 4.47 | ||||
|
| 0.35 | 1.46 | 1.50 | 0.03 | 1.63 | 1.63 | 1.81 | 1.81 | 2.12 | 2.12 | |||
| SMLE |
| 4.22 | 4.34 | 3.68 | 3.75 | 3.59 | 3.66 | 3.95 | 4.02 | ||||
|
| 0.36 | 1.45 | 1.49 | 0.03 | 1.60 | 1.60 | 1.76 | 1.77 | 2.05 | 2.06 | |||
| CMLE |
| 2.77 | 2.77 | 1.81 | 1.81 | 1.29 | 1.29 | 0.98 | 0.98 | ||||
|
| 0.16 | 0.48 | 0.50 | 0.37 | 0.37 | 0.35 | 0.38 | 0.32 | 0.41 | ||||
|
| |||||||||||||
|
| 1.31 | 2.77 | 3.07 | 1.26 | 1.75 | 2.16 | 1.19 | 1.25 | 1.73 | 1.24 | 0.89 | 1.53 | |
|
| 2.14 | 0.51 | 2.20 | 2.15 | 0.32 | 2.17 | 2.16 | 0.23 | 2.17 | 2.15 | 0.16 | 2.16 | |
|
| |||||||||||||
|
| 0.05 | 2.66 | 2.66 | 1.68 | 1.68 | 1.19 | 1.19 | 0.86 | 0.87 | ||||
|
| 0.09 | 0.09 | 0.06 | 0.06 | 0.00 | 0.04 | 0.04 | 0.00 | 0.03 | 0.03 | |||
Coverage probabilities (%) of 95% confidence intervals (CIs) based on non-parametric bootstrap, jackknife (only for ) and sandwich variance estimator for in the second simulation study when dropout is sequentially ignorable. MLE weights: unscaled MLE weights; SMLE weights: scaled MLE weights; CMLE weights: calibrated weights.
|
|
|
|
| ||
|---|---|---|---|---|---|
| Bootstrap, CMLE weights, fixing initial weights |
| 94.3 | 94.0 | 94.7 | 94.7 |
|
| 94.7 | 94.6 | 95.0 | 95.0 | |
| Bootstrap, CMLE weights, re-estimating initial weights |
| 94.3 | 93.8 | 95.0 | 94.5 |
|
| 94.7 | 94.5 | 95.5 | 93.9 | |
| Bootstrap, MLE weights |
| 86.5 | 74.5 | 61.6 | 44.0 |
|
| 91.2 | 91.4 | 92.3 | 90.8 | |
| Bootstrap, SMLE weights |
| 86.8 | 75.9 | 64.3 | 46.5 |
|
| 92.0 | 92.5 | 93.1 | 92.2 | |
| Jackknife, CMLE weights, fixing initial weights |
| 94.7 | 94.7 | ||
|
| 95.0 | 95.4 | |||
| Jackknife, CMLE weights, re-estimating initial weights |
| 94.3 | 94.2 | ||
|
| 93.2 | 93.8 | |||
| Jackknife, MLE weights |
| 96.3 | 96.2 | ||
|
| 95.5 | 94.2 | |||
| Jackknife, SMLE weights |
| 95.7 | 95.5 | ||
|
| 95.0 | 93.7 | |||
| Sandwich variance estimator, MLE weights |
| 94.6 | 93.7 | 94.0 | 94.8 |
|
| 92.3 | 90.5 | 89.9 | 88.4 | |
| Sandwich variance estimator, SMLE weights |
| 94.7 | 93.8 | 94.0 | 94.8 |
|
| 92.4 | 90.5 | 89.8 | 88.5 | |
| Sandwich variance estimator, CMLE weights |
| 97.5 | 98.2 | 98.1 | 98.5 |
|
| 100.0 | 100.0 | 99.9 | 100.0 |
Top: Bias, empirical standard deviation (SD) and root mean squared error (MSE) for IPCWEs of and in the second simulation study. MLE weights: unscaled MLE weights; SMLE weights: scaled MLE weights; CMLE weights: calibrated weights. The naïve analysis without weighting and the analysis based on complete data (‘COMP’) are also presented. Bottom: Bias, empirical standard deviation (SD) and root mean squared error (MSE) of the intercept (‘Int.’) and regression coefficients of baseline covariates and the previous outcome in fitted logistic models for dropout.
|
|
|
|
| ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bias | SD | MSE | Bias | SD | MSE | Bias | SD | MSE | Bias | SD | MSE | ||
| MLE |
| 0.32 | 3.44 | 3.45 | 0.25 | 2.38 | 2.40 | 0.13 | 2.00 | 2.00 | 0.11 | 1.47 | 1.47 |
|
| 0.91 | 0.93 | 0.77 | 0.78 | 0.71 | 0.72 | 0.54 | 0.54 | |||||
| SMLE |
| 0.34 | 3.41 | 3.43 | 0.26 | 2.35 | 2.37 | 0.14 | 1.94 | 1.94 | 0.12 | 1.44 | 1.44 |
|
| 0.90 | 0.93 | 0.76 | 0.77 | 0.70 | 0.71 | 0.53 | 0.53 | |||||
| CMLE |
| 2.76 | 2.76 | 0.02 | 1.77 | 1.77 | 1.24 | 1.24 | 0.01 | 0.89 | 0.89 | ||
|
| 0.02 | 0.27 | 0.28 | 0.01 | 0.19 | 0.19 | 0.01 | 0.14 | 0.14 | 0.00 | 0.11 | 0.11 | |
| Naïve |
| 2.82 | 2.94 | 1.78 | 1.96 | 1.27 | 1.53 | 0.89 | 1.22 | ||||
|
| 0.46 | 1.51 | 0.30 | 1.48 | 0.21 | 1.46 | 0.15 | 1.46 | |||||
| COMP |
| 2.70 | 2.70 | 0.01 | 1.72 | 1.72 | 1.21 | 1.21 | 0.01 | 0.87 | 0.87 | ||
|
| 0.00 | 0.09 | 0.09 | 0.06 | 0.06 | 0.00 | 0.04 | 0.04 | 0.03 | 0.03 | |||
| Int. | 0.00 | 0.12 | 0.12 | 0.00 | 0.07 | 0.07 | 0.00 | 0.05 | 0.05 | 0.00 | 0.04 | 0.04 | |
|
| 0.23 | 0.23 | 0.15 | 0.15 | 0.10 | 0.10 | 0.07 | 0.07 | |||||
|
| 0.01 | 0.14 | 0.14 | 0.00 | 0.09 | 0.09 | 0.00 | 0.06 | 0.06 | 0.00 | 0.04 | 0.04 | |
|
| 0.14 | 0.14 | 0.09 | 0.09 | 0.06 | 0.06 | 0.04 | 0.04 | |||||
|
| 0.14 | 0.14 | 0.09 | 0.09 | 0.06 | 0.06 | 0.04 | 0.04 | |||||
|
| 0.02 | 0.24 | 0.24 | 0.01 | 0.15 | 0.15 | 0.00 | 0.11 | 0.11 | 0.00 | 0.08 | 0.08 | |
Fitted model for the dropout process in the SLICC data. LL: lower limit of 95% CI; UL: upper limit of 95% CI.
| Estimate | Std. Error | LL | UL | ||
|---|---|---|---|---|---|
| Intercept | 2.19 | 0.24 | 1.71 | 2.66 | <0.01 |
| Visit | <0.01 | ||||
| (linear term) | 1.23 | 0.49 | 0.27 | 2.18 | |
| (quadratic term) | 0.54 | 0.61 | |||
| Male | 0.03 | 0.12 | 0.26 | 0.82 | |
| Age at SLE diagnosis | 0.06 | ||||
| (linear term) | 0.09 | 0.04 | 0.00 | 0.18 | |
| (quadratic term) | 0.03 | ||||
| Post-secondary education (yes) | 0.05 | 0.08 | 0.20 | 0.51 | |
| Race/location groups (vs. EU/Canada Caucasian) | <0.01 | ||||
| US Caucasian | 0.11 | ||||
| Hispanic | 0.12 | ||||
| US African | 0.13 | ||||
| Other African | 0.07 | 0.17 | 0.39 | ||
| Asian | 0.12 | ||||
| Other races | 0.19 | ||||
| Corticosteroids use (yes) | 0.05 | 0.08 | 0.21 | 0.57 | |
| Antimalarial use (yes) | 0.17 | 0.08 | 0.02 | 0.33 | 0.03 |
| Immuno-suppressant use (yes) | 0.14 | 0.08 | 0.30 | 0.09 | |
| SLEDAI | 0.05 | 0.04 | 0.12 | 0.19 | |
| SDI w/o NP | 0.01 | ||||
| 1 vs. 0 | 0.11 | ||||
| 2 vs. 0 | 0.05 | 0.15 | 0.35 | ||
| 3 vs. 0 | 0.20 | 0.00 | |||
| >=4 vs. 0 | 0.22 | ||||
| NA vs. 0 | 0.12 | 0.12 | |||
| NP status | 0.47 | ||||
| Other NP w/o CerVE vs. CerVE | 0.15 | 0.20 | 0.55 | ||
| No NP vs. CerVE | 0.07 | 0.20 | 0.46 | ||
| PCS at the previous visit | 0.03 | 0.04 | 0.11 | 0.39 |
Figure 1.Violin plots and scatterplot of the MLE weights (MLE: unscaled MLE weights; SMLE: scaled MLE weights) and calibrated weights assuming sequential ignorability of the dropout process in the SLICC data.
Demographics summaries in the target population (Target) and the weighted samples using the unscaled MLE weights (MLE), scaled MLE weights (SMLE) and calibrated weights (CMLE) in the SLICC data analysis.
| Target | MLE | SMLE | CMLE | |
|---|---|---|---|---|
| Gender (number of observations before study cut-off) | ||||
| Female | 11524 | 12794.99 | 11546.33 | 11524 |
| Male | 1363 | 1484.25 | 1340.67 | 1363 |
| Race/location (number of observations before study cut-off) | ||||
| EU/Canada Caucasian | 4609 | 5153.05 | 4651.06 | 4609 |
| US Caucasian | 1778 | 1907.95 | 1722.55 | 1778 |
| Hispanic | 1785 | 2031.99 | 1832.45 | 1785 |
| US African | 1121 | 1183.01 | 1068.61 | 1121 |
| Other African | 987 | 1104.38 | 996.62 | 987 |
| Asian | 2105 | 2354.79 | 2124.59 | 2105 |
| Other | 502 | 544.06 | 491.13 | 502 |
| Age at SLE diagnosis | ||||
| Mean | 34.67 | 34.57 | 34.57 | 34.67 |
| Standard deviation | 13.30 | 13.27 | 13.27 | 13.30 |
Point estimates (EST) and bootstrap standard errors (SE) of regression coefficients from the naïve analysis without weighting and IPCWEs with the MLE weights and calibrated weights. MLE (unscaled and scaled): weights based on maximum likelihood; CMLE: calibrated weights. SE1: bootstrap standard errors by recalculating the initial weights for calibrating weights; SE2: bootstrap standard errors by fixing the initial weights for calibrating weights. is the coefficient of the current longitudinal outcome in the dropout model, that is, the sensitivity parameter. For sensitivity analysis, we allow to vary at 1–4 times of the estimated coefficient (0.03) of the previous outcome in the dropout model assuming sequential ignorability. Here we only present the result when .
| Naïve |
|
| ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MLE (unscaled) | MLE (scaled) | CMLE | MLE (unscaled) | MLE (scaled) | CMLE | |||||||||||
| EST | SE | EST | SE | EST | SE | EST | SE1 | SE2 | EST | SE | EST | SE | EST | SE1 | SE2 | |
| Intercept | 38.06 | 1.57 | 38.57 | 1.74 | 38.51 | 1.73 | 38.23 | 1.71 | 1.72 | 38.63 | 1.75 | 38.57 | 1.74 | 38.29 | 1.72 | 1.72 |
| Visit | ||||||||||||||||
| (linear term) | 11.92 | 1.45 | 10.72 | 1.66 | 10.90 | 1.65 | 11.04 | 1.63 | 1.66 | 10.51 | 1.66 | 10.69 | 1.64 | 10.84 | 1.63 | 1.67 |
| (quadratic term) | 1.48 | 1.77 | 1.76 | 1.78 | 1.78 | 1.77 | 1.76 | 1.78 | 1.78 | |||||||
| NP status | ||||||||||||||||
| Other NP w/o CerVE vs. CerVE | 1.59 | 1.46 | 1.72 | 1.57 | 1.72 | 1.56 | 1.96 | 1.57 | 1.56 | 1.70 | 1.58 | 1.70 | 1.57 | 1.92 | 1.57 | 1.57 |
| No NP vs. CerVE | 5.03 | 1.42 | 4.91 | 1.53 | 4.90 | 1.52 | 5.13 | 1.53 | 1.53 | 4.89 | 1.54 | 4.88 | 1.53 | 5.10 | 1.54 | 1.54 |
| Male | 3.21 | 0.79 | 3.41 | 0.86 | 3.40 | 0.86 | 3.28 | 0.86 | 0.87 | 3.41 | 0.87 | 3.40 | 0.86 | 3.28 | 0.86 | 0.87 |
| Age at SLE diagnosis | 0.25 | 0.31 | 0.30 | 0.30 | 0.30 | 0.31 | 0.30 | 0.30 | 0.30 | |||||||
| Race/location groups | ||||||||||||||||
| (vs. EU/Canada Caucasian) | ||||||||||||||||
| US Caucasian | 0.96 | 1.19 | 1.18 | 1.13 | 1.15 | 1.18 | 1.17 | 1.12 | 1.15 | |||||||
| Hispanic | 3.13 | 0.78 | 3.93 | 0.88 | 3.91 | 0.87 | 3.74 | 0.85 | 0.85 | 3.91 | 0.88 | 3.89 | 0.88 | 3.73 | 0.85 | 0.86 |
| US African | 1.04 | 0.65 | 1.23 | 0.61 | 1.22 | 0.48 | 1.17 | 1.17 | 0.58 | 1.22 | 0.54 | 1.21 | 0.42 | 1.17 | 1.17 | |
| Other African | 0.95 | 0.98 | 0.97 | 0.96 | 0.96 | 0.98 | 0.97 | 0.96 | 0.96 | |||||||
| Asian | 3.42 | 0.69 | 3.64 | 0.74 | 3.62 | 0.74 | 3.52 | 0.73 | 0.73 | 3.63 | 0.74 | 3.62 | 0.74 | 3.52 | 0.73 | 0.73 |
| Other races | 1.30 | 1.42 | 1.41 | 1.38 | 1.38 | 1.43 | 1.42 | 1.39 | 1.39 | |||||||
| Post-secondary education (yes) | 1.38 | 0.52 | 1.06 | 0.55 | 1.07 | 0.54 | 1.16 | 0.53 | 0.54 | 1.04 | 0.55 | 1.05 | 0.55 | 1.14 | 0.54 | 0.54 |
| SLEDAI | 0.16 | 0.18 | 0.18 | 0.18 | 0.18 | 0.18 | 0.18 | 0.18 | 0.18 | |||||||
| SDI w/o NP | ||||||||||||||||
| 1 vs. 0 | 0.60 | 0.72 | 0.72 | 0.71 | 0.70 | 0.72 | 0.71 | 0.71 | 0.70 | |||||||
| 2 vs. 0 | 0.88 | 1.05 | 1.05 | 1.02 | 1.01 | 1.05 | 1.05 | 1.02 | 1.01 | |||||||
| 3 vs. 0 | 1.27 | 1.25 | 1.25 | 1.27 | 1.25 | 1.25 | 1.25 | 1.27 | 1.25 | |||||||
| >=4 vs. 0 | 1.89 | 1.82 | 1.82 | 1.84 | 1.86 | 1.82 | 1.82 | 1.85 | 1.87 | |||||||
| NA vs. 0 | 0.44 | 0.47 | 0.46 | 0.45 | 0.45 | 0.47 | 0.46 | 0.45 | 0.45 | |||||||
| Corticosteroids use (yes) | 0.48 | 0.56 | 0.55 | 0.53 | 0.53 | 0.56 | 0.55 | 0.53 | 0.53 | |||||||
| Antimalarial use (yes) | 0.04 | 0.48 | 0.54 | 0.00 | 0.53 | 0.10 | 0.53 | 0.53 | 0.54 | 0.00 | 0.53 | 0.11 | 0.53 | 0.53 | ||
| Immuno-suppressant use (yes) | 0.47 | 0.55 | 0.55 | 0.52 | 0.52 | 0.55 | 0.55 | 0.52 | 0.52 | |||||||
Figure 2.Estimated regression coefficients and 95% bootstrap confidence intervals for the SLICC data. Top left panel: changes of mean physical summary score (PCS) from baseline to visit 5. Top right panel: effect of corticosteroids use on PCS. Bottom panels: the long-term effect of the occurrence of cerebrovascular (CerVE) events or any other neuropsychiatric (NP) events on PCS. Dotted line: results from calibrated weights; solid lines: results from scaled MLE weights. The estimated effects with 95% CI covering zero and not covering zero are in grey and black, respectively. is the coefficient of the current longitudinal outcome in the dropout model, that is, the sensitivity parameter. For sensitivity analysis, we allow to vary from one to four times of the coefficient estimate of the previous outcome in the dropout model assuming sequential ignorability.